Data Pulse: A Five-Time Increase in Use of Medisafe for Obesity Meds
A $260.6B Challenge: How Patients Manage Obesity Meds
Weight Management affects 650M people worldwide. Four million people die each year as a result of obesity, according to the World Health Organization [1], making it a serious global problem. Annual obesity-related medical care costs in the United States, were estimated to be $260.6B.
In the last 5 years, the popularity of medications that Medisafe users took for obesity has doubled. That jump was propelled mostly by Semaglutide medications: Wegovy and Ozempic. These meds had not substituted for types of anti-obesity meds – rather they added new patients to the population of users taking meds for weight control.
